The article discusses the appeal of dividend stocks amid market shifts and the impact of interest rate changes. Pfizer Inc. is highlighted as a beaten-down dividend stock with potential, despite challenges faced due to declining vaccine demand. Pfizer's strong dividend track record and financial performance make it an attractive investment option.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing